Dr. Goldberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5141 Broadway
New York, NY 10034Phone+1 212-932-4439
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
Johns Hopkins UniversityResidency, Internal Medicine, 2003 - 2006- Johns Hopkins University School of MedicineClass of 2003
Certifications & Licensure
NY State Medical License 2006 - 2025
Clinical Trials
- Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
- Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Start of enrollment: 2012 Dec 01
- A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma Start of enrollment: 2013 Jul 16
- Join now to see all
Publications & Presentations
PubMed
- 198 citationsTalquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma.Ajai Chari, Monique C Minnema, Jesus G Berdeja, Albert Oriol, Niels W C J van de Donk
The New England Journal of Medicine. 2022-12-15 - 362 citationsTeclistamab in Relapsed or Refractory Multiple Myeloma.Philippe Moreau, Alfred L Garfall, Niels W C J van de Donk, Hareth Nahi, Jesús F San-Miguel
The New England Journal of Medicine. 2022-08-11 - 5 citationsLow-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem c...Maria Sola, Valkal Bhatt, Meighan Palazzo, Kathleen E Cavalier, Sean M Devlin
Bone Marrow Transplantation. 2022-07-01
Abstracts/Posters
- Translational Analysis from CARTITUDE-1, an Ongoing Phase 1b/2 Study of JNJ-4528 BCMA-targeted CAR-T Cell Therapy in Relapsed and/or Refractory Multiple Myeloma (R/R M...Jenna D. Goldberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Results from CARTITUDE-1: A Phase 1b/2 Study of JNJ-4528, a CAR-T Cell Therapy Directed Against B-Cell Maturation Antigen (BCMA), in Patients with Relapsed and/or Refr...Jenna D. Goldberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
